Follow-The-Filings

Security · featured owners

DFTX Definium Therapeutics Ord

Health Care EQUITY Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.3%
  • $41M
  • 2 new

DFTX (Definium Therapeutics Ord) is held in 2 featured 13F books as of 2026 Q2. Stanley Druckenmiller - Duquesne Family Office is the largest tracked holder by portfolio weight (0.32%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Stanley Druckenmiller - Duquesne Family Office) · not free-float ownership

  1. Stanley Druckenmiller new 0.32%
  2. Ron Baron new 0.04%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 0.04% New 0.04% 520,108 $24M history
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.32% New 0.32% 356,600 $17M history

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 6 rows shown

Filed Form Detail Links
4 Period Sep 14, 2026 · 5 forms Filing Doc
4 Period Sep 2, 2026 Filing Doc
4 Period Aug 12, 2026 · 5 forms Filing Doc
4 Period Jun 25, 2026 · 5 forms Filing Doc
4 Period Jun 22, 2026 · 5 forms Filing Doc
4 Period Jun 11, 2026 · 4 forms Filing Doc

Updated 1 day ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$95.73M -$108.68M -$183.79M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $103.87M $281.62M $419.32M
Total non-current assets * $20.67M $20.53M $20.78M
Total assets $124.54M $302.15M $440.1M
Total current liabilities $32.25M $38.85M $66.7M
Total non-current liabilities * $14.16M $21.85M $41.08M
Total equity $78.13M $241.45M $332.33M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$64.36M -$79.13M -$131.56M
Cash from investing — — -$151.61M
Cash from financing $21.85M $253.2M $267.27M
Net change in cash -$42.44M $174.04M -$15.9M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders